Skip to main content

Advertisement

Log in

Novel heterozygous COL4A2 variant c.2572A > G, p.(I858V) mimicking Sneddon’s and Divry van Bogaert Syndrome

  • Letter to the Editors
  • Published:
Journal of Neurology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

References

  1. Bersano A, Morbin M, Ciceri E et al (2016) The diagnostic challenge of Divry van Bogaert and Sneddon Syndrome: report of three cases and literature review. J Neurol Sci 364:77–83. https://doi.org/10.1016/j.jns.2016.03.011

    Article  PubMed  Google Scholar 

  2. Greisenegger EK, Llufriu S, Chamorro A et al (2021) A NOTCH3 homozygous nonsense mutation in familial Sneddon syndrome with pediatric stroke. J Neurol 268:810–816. https://doi.org/10.1007/s00415-020-10081-5

    Article  CAS  PubMed  Google Scholar 

  3. Wu S, Xu Z, Liang H (2014) Sneddon’s syndrome: a comprehensive review of the literature. Orphanet J Rare Dis 9:215. https://doi.org/10.1186/s13023-014-0215-4

    Article  PubMed  PubMed Central  Google Scholar 

  4. Brown CW, Brodsky AS, Freiman RN (2015) Notch3 overexpression promotes anoikis resistance in epithelial ovarian cancer via upregulation of COL4A2. Mol Cancer Res 13:78–85. https://doi.org/10.1158/1541-7786.MCR-14-0334

    Article  CAS  PubMed  Google Scholar 

  5. Yilmaz E, Arsava EM, Gocmen R et al (2021) Characteristic imaging features of neurovascular involvement in primary Sneddon’s syndrome: an analysis of 12 cases. Neurol Sci 42:2363–2369. https://doi.org/10.1007/s10072-020-04621-0

    Article  PubMed  Google Scholar 

  6. Rannikmäe K, Sivakumaran V, Millar H et al (2017) COL4A2 is associated with lacunar ischemic stroke and deep ICH: meta-analyses among 21,500 cases and 40,600 controls. Neurology 89:1829–1839. https://doi.org/10.1212/WNL.0000000000004560

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Richards S, Aziz N, Bale S et al (2015) Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 17:405–424. https://doi.org/10.1038/gim.2015.30

    Article  PubMed  PubMed Central  Google Scholar 

  8. Volonghi I, Pezzini A, Del Zotto E et al (2010) Role of COL4A1 in basement-membrane integrity and cerebral small-vessel disease. The COL4A1 stroke syndrome. Curr Med Chem 17:1317–1324. https://doi.org/10.2174/092986710790936293

    Article  CAS  PubMed  Google Scholar 

  9. Kuo DS, Labelle-Dumais C, Gould DB (2012) COL4A1 and COL4A2 mutations and disease: insights into pathogenic mechanisms and potential therapeutic targets. Hum Mol Genet 21:R97-110. https://doi.org/10.1093/hmg/dds346

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Verbeek E, Meuwissen ME, Verheijen FW et al (2012) COL4A2 mutation associated with familial porencephaly and small-vessel disease. Eur J Hum Genet 20:844–851. https://doi.org/10.1038/ejhg.2012.20

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Jeanne M, Labelle-Dumais C, Jorgensen J et al (2012) COL4A2 mutations impair COL4A1 and COL4A2 secretion and cause hemorrhagic stroke. Am J Hum Genet 90:91–101. https://doi.org/10.1016/j.ajhg.2011.11.022

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Vahedi K, Alamowitch S (2011) Clinical spectrum of type IV collagen (COL4A1) mutations: a novel genetic multisystem disease. Curr Opin Neurol 24:63–68. https://doi.org/10.1097/WCO.0b013e32834232c6

    Article  CAS  PubMed  Google Scholar 

  13. Bersano A, Kraemer M, Burlina A et al (2021) Heritable and non-heritable uncommon causes of stroke. J Neurol 268:2780–2807. https://doi.org/10.1007/s00415-020-09836-x

    Article  CAS  PubMed  Google Scholar 

  14. Mancuso M, Arnold M, Bersano A et al (2020) Monogenic cerebral small-vessel diseases: diagnosis and therapy. Consensus recommendations of the European Academy of Neurology. Eur J Neurol 27:909–927. https://doi.org/10.1111/ene.14183

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jan K. Focke.

Ethics declarations

Conflicts of interest

Jan K. Focke declares no conflict of interest. Roland Veltkamp has received fees for consulting and speaker honoraria from Bayer, Boehringer Ingelheim, BMS, Pfizer, Daich Sankyo, Portola, Biogen, Medtronic, Morphosys, Amgen as well as research support from Bayer, Boehringer, BMS, Pfizer, Daiichi Sankyo, Medtronic, Biogen outside of the present work. Peter Bauer is employee of Centogene Gmbh. Markus Kraemer has received speaker honoraria from Roche Pharma and Chugai Pharma.

Ethical approval

The case report was conducted in accordance with local ethical requirements.

Informed consent

The patients gave their written and informed consent for genetic analyses.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Focke, J.K., Veltkamp, R., Bauer, P. et al. Novel heterozygous COL4A2 variant c.2572A > G, p.(I858V) mimicking Sneddon’s and Divry van Bogaert Syndrome. J Neurol 269, 5153–5156 (2022). https://doi.org/10.1007/s00415-022-11111-0

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00415-022-11111-0

Navigation